About this trial
Preschool children have specific anatomical and physiological characteristics which necessitates careful selection of an appropriate airway management device. Supraglottic airway devices can be used in anticipated or unanticipated difficult airway providing continuous oxygenation and ventilation with less hemodynamic stress response and less postoperative complications. So alternative techniques such as SADs have gained prominence in pediatric anesthesia both as primary airway and as a conduit for endotracheal intubation. So this study will evaluate the clinical performance of Laryseal Clear and Ambu Aura40 laryngeal mask airway in preschool children undergoing surgical procedures.
Eligibility criteria
Qualifiers
Consent of patient's parents or guardians of the first degree.
American Society of Anesthesiologists (ASA) Class I or II.
BMI: 5-85% of the children of the same age and sex.
Patients with mallampati grade I, II
Disqualifiers
Emergency surgeries.
Expected difficult airway.
Patients with congenital or acquired airway malformations.
Patients with active upper respiratory tract infection at the time of surgery.
Trial design
Treatments tested in this trial
- LarySeal clear Group
- Ambu Aura40 Group